| Hartmann EL, Gatesman M, Roskopf-Somerville J, et al.
Management of leukopenia in kidney and pancreas transplant recipients. [Journal Article]
Clin Transplant 2008 Nov-Dec; 22(6):822-8.
Abstract | Full Citation | Find Related Articles | | Fernández-Ruiz M, Muñoz-Codoceo C, López-Medrano F, et al.
Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir. [Journal Article]
Intern Med 2008; 47(22):1963-6.
Abstract | Full Citation | Find Related Articles | | de la Cruz-Vicente F, Cerezuela Martinez P, Gil-Espárraga E, et al.
Preemptive therapy for cytomegalovirus disease in allogeneic stem cell transplant recipients. [Journal Article]
Transplant Proc 2008 Nov; 40(9):3102-3.
Abstract | Full Citation | | Moro JA, Almenar L, Martínez-Dolz L, et al.
Utility of oral valganciclovir for cytomegalovirus prophylaxis: does it improve treatment compliance? [Journal Article]
Transplant Proc 2008 Nov; 40(9):3063-4.
Abstract | Full Citation | Find Related Articles | | Lamoth F, Manuel O, Venetz JP, et al.
What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation? [Letter]
Transplantation 2008 Nov 15; 86(9):1323-4.
Full Citation | Publisher Full Text | Find Related Articles | | Griffiths P, Whitley R, Snydman DR, et al.
Contemporary Management of Cytomegalovirus Infection in Transplant Recipients: Guidelines from an IHMF((R)) Workshop, 2007. [Journal Article]
Herpes 2008; 15(1):4-12.
Abstract | Full Citation | Find Related Articles | | Sarmiento E, Lanio N, Gallego A, et al.
Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation. [JOURNAL ARTICLE]
Int Immunopharmacol 2008 Oct 18.
Abstract | Full Citation | Find Related Articles | | Sloan DJ, Taegtmeyer M, Pearce IA, et al.
Cytomegalovirus retinitis in the absence of HIV or immunosuppression. [JOURNAL ARTICLE]
Eur J Ophthalmol 2008 September-October.:813-815.
Abstract | Full Citation | | Focosi D, Benedetti E, Maggi F, et al.
Preemptive valganciclovir for cytomegalovirus infection in hematological patients. [Comment, Letter]
Transpl Infect Dis 2008 Oct; 10(5):375-6.
Full Citation | | Hwang YY, Cheung WW, Leung AY, et al.
Valganciclovir thrice weekly for prophylaxis against cytomegalovirus reactivation during alemtuzumab therapy. [JOURNAL ARTICLE]
Leukemia 2008 Oct 9.
Full Citation |   |
|
| |
Advertise on this site.
|
